Aripiprazole, sold under the brand names Abilify and Aristada, among others, is an atypical antipsychotic. It is primarily used in the treatment of schizophrenia...
105 KB (9,710 words) - 19:54, 1 August 2024
Aripiprazole lauroxil, sold under the brand name Aristada, is a long-acting injectable atypical antipsychotic that was developed by Alkermes. It is an...
17 KB (1,741 words) - 17:05, 30 September 2023
Aripiprazole/sertraline (developmental code name ASC-01) is a combination formulation of aripiprazole (Abilify), an atypical antipsychotic, and sertraline...
3 KB (157 words) - 02:21, 5 November 2023
The rates of adverse effects of aripiprazole are: Weight gain Headache Agitation Insomnia Anxiety Nausea & vomiting Akathisia — a sense of unease and restlessness...
9 KB (723 words) - 14:13, 12 April 2024
developed by Otsuka and Lundbeck, and is considered to be a successor to aripiprazole (Abilify). It was approved for medical use in the United States in July...
31 KB (2,342 words) - 16:44, 31 July 2024
hyperactive muscle fibres thus reducing involuntary movement production. Aripiprazole is an FDA-approved antipsychotic drug that "acts as an antagonist at...
23 KB (2,742 words) - 17:35, 1 June 2024
effects complicate the choice. In turn, risperidone, olanzapine, and aripiprazole have been recommended for the treatment of first-episode psychosis. The...
100 KB (9,280 words) - 14:32, 7 April 2024
Pipotiazine undecylenate Zuclopenthixol acetate Zuclopenthixol decanoate Aripiprazole lauroxil Paliperidone palmitate ATC code N05A DrugBank WHO ATC codes...
8 KB (49 words) - 20:57, 11 August 2023
antipsychotic to an (or to a different) atypical antipsychotic, such as aripiprazole, ziprasidone, quetiapine, olanzapine, risperidone, or clozapine. These...
13 KB (1,359 words) - 06:00, 24 March 2024
drug normalised to some extent the dopaminergic hyperactive state. Aripiprazole's mode of action differs from other atypical antipsychotics in its selectivity...
10 KB (1,058 words) - 20:48, 27 January 2023